Gene · 5921
Papers3,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,461 to 1,480 of 3,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LncRNA PLAC 2 downregulated miR-21 in non-small cell lung cancer and predicted survival. | BMC Pulm Med | 2019 | 31500623 | PubTator, text mining | PubMed |
| Morpho-Molecular Assessment Indicates New Prognostic Aspects and Personalized Therapeutic Options in Sinonasal Melanoma. | Cancers (Basel) | 2019 | 31500314 | PubTator, text mining | PubMed |
| Transcriptome analyses of tumor-adjacent somatic tissues reveal genes co-expressed with transposable elements. | Mob DNA | 2019 | 31497073 | PubTator, text mining | PubMed |
| Intramuscular fast-flow vascular anomaly contains somatic MAP2K1 and KRAS mutations. | Angiogenesis | 2019 | 31486960 | PubTator, text mining | PubMed |
| EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma. | Oncogenesis | 2019 | 31484920 | PubTator, text mining | PubMed |
| Circular RNAs in cancer: new insights into functions and implications in ovarian cancer. | J Ovarian Res | 2019 | 31481095 | PubTator, text mining | PubMed |
| The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis. | J Exp Clin Cancer Res | 2019 | 31481087 | PubTator, text mining | PubMed |
| Rasal2 suppresses breast cancer cell proliferation modulated by secretory autophagy. | Mol Cell Biochem | 2019 | 31473883 | PubTator, text mining | PubMed |
| Significance of miR-27a and miR-31 in early diagnosis and prognosis of colorectal cancer. | Oncol Lett | 2019 | 31452786 | PubTator, text mining | PubMed |
| Efficient Mining of Variants From Trios for Ventricular Septal Defect Association Study. | Front Genet | 2019 | 31440271 | PubTator, text mining | PubMed |
| Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study? | J Exp Clin Cancer Res | 2019 | 31439015 | PubTator, text mining | PubMed |
| Weighted correlation network analysis of triple-negative breast cancer progression: Identifying specific modules and hub genes based on the GEO and TCGA database. | Oncol Lett | 2019 | 31423181 | PubTator, text mining | PubMed |
| Pathogenic Mutations Associated with Legius Syndrome Modify the Spred1 Surface and Are Involved in Direct Binding to the Ras Inactivator Neurofibromin. | J Mol Biol | 2019 | 31401120 | PubTator, text mining | PubMed |
| Phenotypic characterization of individuals with SYNGAP1 pathogenic variants reveals a potential correlation between posterior dominant rhythm and developmental progression. | J Neurodev Disord | 2019 | 31395010 | PubTator, text mining | PubMed |
| A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation. | Cell Rep | 2019 | 31390566 | PubTator, text mining | PubMed |
| Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data. | J Transl Med | 2019 | 31387579 | PubTator, text mining | PubMed |
| Endogenous IQGAP1 and IQGAP3 do not functionally interact with Ras. | Sci Rep | 2019 | 31363101 | PubTator, text mining | PubMed |
| Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer. | Nucleic Acids Res | 2019 | 31340025 | PubTator, text mining | PubMed |
| A meta-analysis of multiple matched aCGH/expression cancer datasets reveals regulatory relationships and pathway enrichment of potential oncogenes. | PLoS One | 2019 | 31335867 | PubTator, text mining | PubMed |
| The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling. | Oncogene | 2019 | 31312020 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5921/papers?page=74